is tirzepatide being discontinued A Major GLP-1 Drug Shortage Over. Some Patients Aren't Celebrating FDA Moves to Permanently Close

Additional risks include the potential for medication errors when attempting to measure or divide doses not provided in pre-filled pens, particularly if patients are using compounded formulations of uncertain quality and potency

Ask whether a slower dose escalation or a lower maintenance dose might reduce sexual side effects while preserving weight loss benefits

Berberine in the treatment of insulin resistance and type 2 diabetes mellitus: A review. Biotechnol Adv

The pill, which shares the same active ingredient as Wegovy, is expected to be available in early 2026

Clinical trails show that Mounjaro leads to an average weight loss of nearly 25% after one year, compared to Wegovy's average weight loss of around 16%

Target ferritin levels above 40 ng/mL (some dermatologists recommend 70+ for optimal hair growth)